Suzuken Co (9987) Price & Analysis

Compare

0 Followers

9987 Stock Chart & Stats

¥6337.00

-¥26.00(-0.55%)

At close: Jan 08 4:00 PM EST

¥6337.00

-¥26.00(-0.55%)

Day’s Range― - ―

52-Week Range¥4,406.00 - ¥6,668.00

Previous CloseN/A

Volume197.40K

Average Volume (3M)163.97K

Market Cap

¥360.46B

Enterprise Value¥251.08B

Total Cash (Recent Filing)¥142.20B

Total Debt (Recent Filing)¥23.85B

Price to Earnings (P/E)7.2

Beta0.43

Next Earnings

May 18, 2026

EPS Estimate

97.55

Next Dividend Ex-DateN/A

Dividend Yield1.6%

Share Statistics

EPS (TTM)211.65

Shares Outstanding72,167,206

10 Day Avg. Volume143,650

30 Day Avg. Volume163,966

Financial Highlights & Ratios

PEG Ratio0.40

Price to Book (P/B)0.92

Price to Sales (P/S)0.16

P/FCF Ratio-4.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)452.83

Revenue Forecast (FY)¥2.49T

Bulls Say, Bears Say

Bulls Say

Very Low Leverage / Strong Balance SheetAn almost negligible debt-to-equity ratio provides durable financial flexibility for a distribution business that needs to finance inventory and working capital. Low leverage reduces refinancing risk, supports investment in logistics, and cushions the company through industry cyclicality over months.

Stable Gross Margins And Improving ProfitabilityConsistent gross margins and modest improvements in operating margins indicate effective cost and procurement management in distribution. Margin stability supports long-term cash generation potential per unit of revenue and helps the company preserve profitability despite volume fluctuations.

Core Essential Wholesale Distribution ModelPharmaceutical wholesale is a structurally recurring, high-frequency business with sticky customers (hospitals, pharmacies) and regulatory barriers to entry. Scale in logistics and inventory services creates durable revenue streams and long-term customer relationships for recurring volumes.

Bears Say

Sharp Revenue DeclineA steep, persistent drop in revenue materially undermines scale advantages in distribution, reduces bargaining leverage with manufacturers, and impairs fixed-cost absorption. Over a multi-month horizon this can erode margins, service levels, and the cash conversion profile.

Negative Operating And Free Cash FlowsNegative operating and free cash flows signal impaired cash conversion despite accounting profits. For a logistics-heavy wholesaler, this strains the ability to fund inventory and working capital internally, increasing reliance on external financing or asset sales and limiting strategic investments.

Business Exposed To Volume And Liquidity ShocksThe company's model depends on high volumes and tight cash management; combined revenue and cash flow deterioration creates structural vulnerability. Over months, sustained volume shocks can weaken service capabilities, raise working-capital costs, and harm competitive positioning versus larger integrated distributors.

Suzuken Co News

Suzuken Completes ¥26 Billion Share Buyback Program

Suzuken Co ( ($JP:9987) ) has shared an update. Suzuken has completed a share repurchase program authorized in...

21h ago

Suzuken Nears Completion of ¥26 Billion Share Buyback Program

The latest announcement is out from Suzuken Co ( ($JP:9987) ). Suzuken has provided an update on its...

8d ago

Suzuken Reshapes Pharmaceutical Logistics with Intra-Group Split and New Subsidiary

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken will restructure its intra-group logistics operations by carving...

26d ago

Suzuken posts higher sales but weaker profits and lower equity ratio for nine months

Suzuken Co ( ($JP:9987) ) has issued an announcement. Suzuken reported consolidated net sales of ¥1.89 trillion for...

26d ago

Suzuken Updates Progress on Ongoing Share Repurchase Program

An announcement from Suzuken Co ( ($JP:9987) ) is now available. Suzuken Co., Ltd. reported the January 2026...

1M ago

Suzuken Advances Toward Completion of ¥26 Billion Share Buyback Program

The latest update is out from Suzuken Co ( ($JP:9987) ). Suzuken Co., Ltd. reported that it repurchased...

2M ago

Suzuken Co. Updates on November 2025 Share Repurchase

Suzuken Co ( ($JP:9987) ) has shared an update. Suzuken Co., Ltd. announced the results of its share...

3M ago

Suzuken Co. Completes Share Repurchase to Enhance Capital Flexibility

Suzuken Co ( ($JP:9987) ) has issued an announcement. Suzuken Co., Ltd. announced the completion of a share...

4M ago

Suzuken Co. Updates on Share Repurchase Progress

An update from Suzuken Co ( ($JP:9987) ) is now available. Suzuken Co., Ltd. announced the results of...

4M ago

Suzuken Co. Announces Share Repurchase Plan

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co., Ltd. has announced a share repurchase plan,...

4M ago

Suzuken upgraded to Buy from Hold at Jefferies

Jefferies upgraded Suzuken to Buy from Hold with a price target of 5,900 yen, up from 5,200 yen....

2y ago

Suzuken downgraded to Neutral from Buy at Citi

Citi downgraded Suzuken to Neutral from Buy with a price target of 5,200 yen, up from 4,800 yen....

2y ago

SZUKF

9987 FAQ

What was Suzuken Co Ltd’s price range in the past 12 months?

Suzuken Co Ltd lowest stock price was ¥4406.00 and its highest was ¥6668.00 in the past 12 months.

What is Suzuken Co Ltd’s market cap?

Suzuken Co Ltd’s market cap is ¥360.46B.

When is Suzuken Co Ltd’s upcoming earnings report date?

Suzuken Co Ltd’s upcoming earnings report date is May 18, 2026 which is in 70 days.

How were Suzuken Co Ltd’s earnings last quarter?

Suzuken Co Ltd released its earnings results on Feb 12, 2026. The company reported ¥211.65 earnings per share for the quarter, beating the consensus estimate of ¥97.202 by ¥114.448.

Is Suzuken Co Ltd overvalued?

According to Wall Street analysts Suzuken Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Suzuken Co Ltd pay dividends?

Suzuken Co Ltd pays a Semiannually dividend of ¥50 which represents an annual dividend yield of 1.6%. See more information on Suzuken Co Ltd dividends here

What is Suzuken Co Ltd’s EPS estimate?

Suzuken Co Ltd’s EPS estimate is 97.55.

How many shares outstanding does Suzuken Co Ltd have?

Suzuken Co Ltd has 72,167,206 shares outstanding.

What happened to Suzuken Co Ltd’s price movement after its last earnings report?

Suzuken Co Ltd reported an EPS of ¥211.65 in its last earnings report, beating expectations of ¥97.202. Following the earnings report the stock price went down -3.638%.

Which hedge fund is a major shareholder of Suzuken Co Ltd?

Currently, no hedge funds are holding shares in JP:9987

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suzuken Co Ltd

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.